01 1Zambon Group SpA
01 1Sam-O Pharmaceutical Co., Ltd.
01 1Oxaprozine
01 1Italy
Registrant Name : Sam-O Pharmaceutical Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-54-C-180-03
Manufacturer Name : Zambon Group SpA
Manufacturer Address : Via Dovaro 36045 Almisano di Lonigo (Vicenza) (Via della Chimica, 9, 36100 Vicenza), ...
89
PharmaCompass offers a list of Oxaprozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oxaprozin manufacturer or Oxaprozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxaprozin manufacturer or Oxaprozin supplier.
A Oxaprozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxaprozin, including repackagers and relabelers. The FDA regulates Oxaprozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxaprozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxaprozin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Oxaprozin supplier is an individual or a company that provides Oxaprozin active pharmaceutical ingredient (API) or Oxaprozin finished formulations upon request. The Oxaprozin suppliers may include Oxaprozin API manufacturers, exporters, distributors and traders.
click here to find a list of Oxaprozin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Oxaprozin Drug Master File in Korea (Oxaprozin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxaprozin. The MFDS reviews the Oxaprozin KDMF as part of the drug registration process and uses the information provided in the Oxaprozin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Oxaprozin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxaprozin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Oxaprozin suppliers with KDMF on PharmaCompass.
We have 1 companies offering Oxaprozin
Get in contact with the supplier of your choice:
